Peripheral Vascular Devices | Market Insights | Europe | 2022
The COVID-19 pandemic had a negative impact on the US PV device market to some extent. Beyond the pandemic, the US market for PV devices will face new challenges brought about by reimbursement changes, while the continued adoption of endovascular treatment and innovative product launches will drive modest growth through 2031.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in the US from 2019 through 2031.